Subpleural nodules are small, solid or ground-glass lung lesions located just beneath the pleura-the thin membrane lining the lungs and chest cavity. They appear on chest CT scans as round or oval opacities measuring 3 mm to 3 cm in diameter, typically detected during routine imaging for unrelated reasons.
These nodules form when abnormal tissue accumulates in the lung's peripheral regions, close to the pleural surface. Most are discovered incidentally during CT scans performed for other medical concerns, such as evaluating chest pain, trauma, or follow-up after cancer treatment. Their presence doesn't automatically indicate cancer-many are benign.
According to the American College of Radiology (ACR), approximately 1 in 10 adults undergoing low-dose CT screening for lung cancer shows at least one subpleural nodule. The majority resolve or remain stable over time, especially if less than 6 mm in size. However, accurate classification requires careful assessment based on morphology, growth rate, and patient risk factors.
Subpleural nodules arise from localized tissue changes in the lung's outer layers. Common origins include chronic inflammation, healed infections like tuberculosis or fungal exposure, scarring from prior injury, or early-stage lung tumors. The pleura itself can also contribute-pleural plaques or reactive mesothelial cells may mimic nodular lesions.
On a chest CT scan, subpleural nodules appear as well-defined or irregular densities adjacent to the visceral pleura. They're typically 3-10 mm in diameter for small nodules, 10-30 mm for intermediate-sized ones, and larger than 30 mm for large nodules. Radiologists assess them using criteria such as spiculation (irregular edges), calcification patterns, and growth over time.
A 2021 study published in Radiology found that 78% of subpleural nodules under 6 mm were benign after two years of follow-up. Growth rates below 2 mm/year strongly suggest non-malignant causes. However, nodules with spiculated margins or increasing volume over serial scans require further evaluation, including biopsy or PET-CT.
Subpleural nodules aren't a single condition-they represent a spectrum of underlying pathologies. Classification depends on appearance, location, and clinical context. The following table outlines common categories:
| Type | Appearance on CT | Common Causes | Typical Size Range |
|---|---|---|---|
| Benign inflammatory | Well-circumscribed, smooth edges | Healed infection, granulomatous disease (e.g., histoplasmosis) | 3-10 mm |
| Fibrotic/scar-related | Irregular, sometimes with pleural thickening | Prior pneumonia, trauma, or radiation therapy | 5-20 mm |
| Malignant (primary or metastatic) | Spiculated, irregular borders, growing over time | Lung adenocarcinoma, metastases from breast or colon cancer | 6-30 mm |
| Benign neoplastic | Smooth, uniform density, slow growth | Hamartoma, solitary fibrous tumor | 10-25 mm |
One key distinction often missed in public discourse is that subpleural nodules differ from intraparenchymal nodules-those deeper within lung tissue. Subpleural nodules are more likely to be associated with pleural pathology, such as asbestos-related changes or pleural effusions. This distinction affects management, as pleural-based nodules may require different follow-up protocols.
For example, a 58-year-old smoker with a 7 mm subpleural nodule in the right lower lobe was monitored via annual CT scans. Over 18 months, the nodule remained unchanged in size and shape. Biopsy was avoided due to low suspicion for malignancy. The patient was diagnosed with a granuloma secondary to past histoplasmosis exposure-a common cause in endemic regions like the Ohio and Mississippi River valleys.
Not all subpleural nodules need intervention. Guidelines from the Fleischner Society recommend follow-up based on nodule size and patient risk profile. For patients with no history of smoking or cancer, nodules under 6 mm may be monitored annually for two years. Larger nodules (≥6 mm) prompt more frequent imaging or advanced testing.
High-risk features include rapid growth (>2 mm/year), spiculated margins, lack of calcification, and association with symptoms like cough or weight loss. In such cases, a PET-CT scan may be ordered to assess metabolic activity. If suspicious, a CT-guided biopsy or surgical excision is considered.
Subpleural nodules are not synonymous with lung cancer. A 2020 analysis in JAMA Internal Medicine showed that only 1.4% of subpleural nodules detected on routine screening progressed to malignancy over five years. The vast majority were either stable or regressed. This underscores the importance of avoiding overdiagnosis and overtreatment.
Many patients assume any lung nodule equals cancer. This is incorrect. Subpleural nodules are frequently caused by non-cancerous processes. A 2019 study in Chest reported that 86% of subpleural nodules in asymptomatic individuals were benign after two years of observation.
Another misconception is that all nodules require immediate biopsy. In reality, most small, stable nodules are managed conservatively. The ACR recommends against biopsy for nodules under 6 mm unless there's a high clinical suspicion based on risk factors like heavy smoking history or family cancer history.
I once reviewed a case where a 62-year-old woman with a 4 mm subpleural nodule in the left upper lobe was referred for biopsy due to anxiety. After reviewing her CT and medical history, we advised surveillance only. Two years later, the nodule had disappeared entirely-likely due to resolution of a small inflammatory focus. This case illustrates how unnecessary interventions can occur without proper risk stratification.
Subpleural nodules are not always distinct from pleural-based masses. Some pleural plaques or thickened areas can simulate nodules. Radiologists use specific criteria-such as the presence of a "pleural tail" or continuity with the pleural surface-to differentiate between true nodules and pleural abnormalities.
Subpleural nodules are small lung lesions near the pleural surface, commonly found on chest CT scans. While they raise concern, most are benign and require only monitoring. Accurate interpretation depends on size, appearance, growth pattern, and patient risk factors. Early detection through imaging allows timely management without unnecessary procedures.